VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 166 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $776,000 | -66.5% | 45,280 | -57.9% | 0.00% | -71.4% |
| Q2 2021 | $2,314,000 | +43.2% | 107,600 | 0.0% | 0.01% | +27.3% |
| Q1 2021 | $1,616,000 | +14.3% | 107,600 | 0.0% | 0.01% | +10.0% |
| Q4 2020 | $1,414,000 | +13.9% | 107,600 | -16.3% | 0.01% | +11.1% |
| Q3 2020 | $1,241,000 | -31.2% | 128,500 | -18.5% | 0.01% | -40.0% |
| Q2 2020 | $1,803,000 | -41.8% | 157,600 | -47.3% | 0.02% | -6.2% |
| Q1 2020 | $3,096,000 | +207.1% | 298,800 | +147.8% | 0.02% | +45.5% |
| Q1 2016 | $1,008,000 | -75.3% | 120,600 | -71.4% | 0.01% | -79.2% |
| Q4 2015 | $4,084,000 | – | 422,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |